-Recognition highlights pioneering contributions to nanomedicine underpinning the company’s RIDE platform Oss, The Netherlands — April 14, 2026 — Trained Therapeutix Discovery, a biotechnology company…
DALLAS and OSS, The Netherlands, Feb. 09, 2026 (GLOBE NEWSWIRE) — Trained Therapeutix Discovery, a pioneering immunotherapy biotech company revolutionizing the treatment of immune-mediated diseases…
Trained Therapeutix Discovery Demonstrates RIDE-001 Trains Myeloid Cells for Anti-Tumor Immune Response in Preclinical Data Presented at the Society for Immunotherapy of Cancer (SITC) Annual…
Trained Therapeutix Discovery Appoints Joost Kreijtz, PhD, as Chief Executive Officer of Dutch Subsidiary Trained Therapeutix Discovery (NL) Dallas, TX & The Netherlands — October…
Trained Therapeutix Discovery is pleased to announce its participation in BIO-Europe, taking place in Vienna from November 3 to 5, 2025. Our management team will…
We talked with them about our company Trained Therapeutix Discovery. With platform technology from Willem Mulder and immunological insights from Mihai Netea, we develop innovative…